Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 5/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | G6PD | P11413 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.50 |
| ▸ | CCR6 | P51684 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | ESR1 | P03372 | 6/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19765499 | 0.90 | ESR1 (0.48) | ALDH1A1ALOX15CYP2C9CYP1A2CYP2C19 | |
| SCHEMBL1245497 | 0.85 | ALOX15 (0.52) | ALDH1A1ALOX15CYP2C9CYP1A2CYP2C19 | |
| SCHEMBL29872696 | 0.85 | ALOX15 (0.52) | ALDH1A1ALOX15CYP2C9CYP1A2CYP2C19 | |
| SCHEMBL9757833 | 0.82 | ESR1 (0.53) | ALDH1A1ALOX15CYP2C9CYP1A2CYP2C19 | |
| SCHEMBL15625205 | 0.82 | ESR1 (0.52) | ALDH1A1ALOX15CYP2C9CYP1A2CYP2C19 | |
| SCHEMBL1501375 | 0.81 | ALOX15 (0.54) | ALDH1A1ALOX15CYP2C9CYP1A2CYP2C19 | |
| SCHEMBL866395 | 0.81 | ALOX15 (0.61) | ALDH1A1ALOX15CYP2C9CYP1A2CYP2C19 | |
| SCHEMBL30747043 | 0.81 | ALOX15 (0.61) | ALDH1A1ALOX15CYP2C9CYP1A2CYP2C19 | |
| SCHEMBL13784872 | 0.79 | ALDH1A1 (0.41) | ALDH1A1ALOX15CYP2C9CYP1A2CYP2C19 | |
| SCHEMBL13609123 | 0.79 | ALOX15 (0.44) | ALDH1A1ALOX15CYP2C9CYP1A2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260132242-A1 | CURABLE RESIN, CURABLE RESIN COMPOSITION, AND CURED PRODUCT | DIC CORPORATION (JP) | 2026-05-14 | — | — | US | disclosed |
| CN-111748077-B | Alkali-soluble resin, hydrogenated compound, method for producing same, resin composition, cured film thereof, touch panel, and optical filter | 日铁化学材料株式会社 | 2025-04-18 | — | — | CN | disclosed |
| US-20250122320-A1 | CURABLE RESIN, CURABLE RESIN COMPOSITION, AND CURED ARTICLE | DIC CORPORATION (JP) | 2025-04-17 | — | — | US | disclosed |
| US-12157793-B2 | Curable resin, curable resin composition, and cured product | DIC CORPORATION (JP) | 2024-12-03 | — | — | US | disclosed |
| US-20240317916-A1 | CURABLE RESIN COMPOSITION AND CURED PRODUCT | DIC CORPORATION (JP) | 2024-09-26 | — | — | US | disclosed |
| US-20240052093-A1 | CURABLE RESIN, CURABLE RESIN COMPOSITION, AND CURED PRODUCT | DIC CORPORATION (JP) | 2024-02-15 | — | — | US | disclosed |
| CN-111367143-B | Black resin composition for light shielding film, substrate with light shielding film, color filter and touch screen | 日铁化学材料株式会社 | 2023-10-31 | — | — | CN | disclosed |
| WO-2023145108-A1 | CURABLE RESIN, CURABLE RESIN COMPOSITION, AND CURED ARTICLE | DIC株式会社 | 2023-08-03 | — | — | WO | disclosed |
| WO-2023089976-A1 | CURABLE RESIN, CURABLE RESIN COMPOSITION, AND CURED OBJECT | DIC株式会社 | 2023-05-25 | — | — | WO | disclosed |
| WO-2023008079-A1 | CURABLE RESIN COMPOSITION AND CURED PRODUCT | DIC株式会社 | 2023-02-02 | — | — | WO | disclosed |
| US-5637398-A | HAVING METAL SULFONATE ENDCAP; RESISTANCE TO LIGHT AND HYDROLYSIS, HIGH FIBER STRENGTH | TOYO BOSEKI KABUSHIKI KAISHA (JP) | 1997-06-10 | — | — | US | disclosed |
| US-5382605-A | Polyesters and/or polycarbonates for articles for medical equipment or moldings | MILES INC. (US) | 1995-01-17 | — | — | US | disclosed |
| EP-0572889-A1 | Polycondensate composition stabilised against ionising-radiation induced degradation | Bayer Corporation (US) | 1993-12-08 | — | — | EP | disclosed |
| US-5214078-A | Polyether and aromatic disulfide, discoloration inhibition | MILES INC. (US) | 1993-05-25 | — | — | US | disclosed |
| EP-0488106-A2 | A polyester fiber | Toyo Boseki Kabushiki Kaisha (JP) | 1992-06-03 | — | — | EP | disclosed |
| US-4725664-A | TEREPHTHALIC ACID, BUTANEDIOL AND ALKOXYLATED BISPHENOL A | CELANESE CORPORATION (US) | 1988-02-16 | — | — | US | disclosed |
| EP-0111849-A1 | Branched copolyester-carbonate resins | GENERAL ELECTRIC COMPANY (US) | 1984-06-27 | — | — | EP | disclosed |
| US-4377682-A | FROM TEREPHTHALIC ACID, OTHER DICARBOXYLIC ACIDS, ETHYLENE GLYCOL, 1,4-BUTANEDIOL, OR 1,4-CYCLOHEXANEDIOL, GLYCOLS | TOYO BOSEKI KABUSHIKI KAISHA (JP) | 1983-03-22 | — | — | US | disclosed |
| US-4045499-A | ACID CATALYSTS | BAYER AKTIENGESELLSCHAFT (DT) | 1977-08-30 | — | — | US | disclosed |
| US-4036906-A | NONHYDROLYZING | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1977-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260132242-A1 | CURABLE RESIN, CURABLE RESIN COMPOSITION, AND CURED PRODUCT | ASH2L, ARL1, CARM1 | ALDH1A1 370/4885ALOX15 2685/4885CYP2C9 2789/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.